Allogeneic cell therapy differs from autologous cell therapy in that it uses cells from a healthy donor rather than the patient's own cells. Clinical trials for allogeneic cell-based therapy have increased significantly in recent years. Over the last five years, the number of clinical trials involving mesenchymal stem cells (MSCs) and cellular therapy has more than doubled. The market has...